Armata Pharmaceuticals (ARMP) Assets Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.00% |
| Dec 31, 2025 | -11.05% |
| Sep 30, 2025 | -8.88% |
| Jun 30, 2025 | -25.41% |
| Mar 31, 2025 | -27.51% |
| Dec 31, 2024 | -12.12% |
| Sep 30, 2024 | -12.88% |
| Jun 30, 2024 | 7.02% |
| Mar 31, 2024 | 10.64% |
| Dec 31, 2023 | 2.64% |
| Sep 30, 2023 | 21.40% |
| Jun 30, 2023 | 0.23% |
| Mar 31, 2023 | 0.94% |
| Dec 31, 2022 | 37.36% |
| Sep 30, 2022 | 117.67% |
| Jun 30, 2022 | 109.16% |
| Mar 31, 2022 | 103.93% |
| Dec 31, 2021 | 76.56% |
| Sep 30, 2021 | -6.58% |
| Jun 30, 2021 | -2.39% |
| Mar 31, 2021 | 19.82% |
| Dec 31, 2020 | 55.26% |
| Sep 30, 2020 | 55.87% |
| Jun 30, 2020 | 41.66% |
| Mar 31, 2020 | 358.58% |
| Dec 31, 2019 | 74.98% |
| Sep 30, 2019 | 175.96% |
| Jun 30, 2019 | 197.92% |
| Mar 31, 2019 | -33.21% |
| Dec 31, 2018 | 30.59% |
| Sep 30, 2018 | -22.94% |
| Jun 30, 2018 | -22.41% |
| Mar 31, 2018 | 0.68% |
| Dec 31, 2017 | -38.64% |
| Sep 30, 2017 | -47.07% |
| Jun 30, 2017 | -48.41% |
| Mar 31, 2017 | -49.39% |
| Dec 31, 2016 | -42.36% |
| Sep 30, 2016 | -23.60% |
| Jun 30, 2016 | -19.50% |